Penetrance of Hypertrophic Cardiomyopathy in Sarcomere Protein Mutation Carriers

Abstract

Following a first negative screening, approximately 50% of SP mutation carriers develop HCM over 15 years of follow-up. Male sex and an abnormal ECG are associated with a higher risk of developing HCM. Regular CMR should be considered in long-term screening.